✦ LIBER ✦

TDP-43 in Alzheimer’s disease is not associated with clinical FTLD or Parkinsonism

✍ Scribed by Jung, Youngsin; Dickson, Dennis W.; Murray, Melissa E.; Whitwell, Jennifer L.; Knopman, David S.; Boeve, Bradley F.; Jack, Clifford R.; Parisi, Joseph E.; Petersen, Ronald C.; Josephs, Keith A.

Book ID: 125347023
Publisher: Springer
Year: 2014
Tongue: English
Weight: 334 KB
Volume: 261
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-014-7352-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical, pathologic and genetic associa

Clinical, pathologic and genetic associations of TDP-43 pathology in Alzheimer's disease

✍ Kofler, Julia; Jiao, Zhuomin; Murdoch, Geoffrey; Snitz, Beth; Wang, Xingbin; Swe 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

TDP-43 pathological changes in early ons

TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s Syndrome: association with age, hippocampal sclerosis and clinical phenotype

✍ Yvonne S. Davidson; Samantha Raby; Penelope G. Foulds; Andrew Robinson; Jennifer 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 464 KB

LINGO1 is not associated with Parkinson'

LINGO1 is not associated with Parkinson's disease in German patients

✍ Stephan Klebe; Sandra Thier; Delia Lorenz; Michael Nothnagel; Stefan Schreiber; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Fatigue in Parkinson's disease is not as

Fatigue in Parkinson's disease is not associated with reduced physical activity

✍ J.I. Hoff; J.J. Van Hilten; H.A.M. Middelkoop; R.A.C. Roos 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 561 KB

Serum α1-antichymotrypsin is not a usefu

Serum α1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease

✍ M. A. Kuiper; G. J. van Kamp; P. L. M. Bergmans; Ph. Scheltens; E. Ch. Wolters 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 323 KB

Homocysteine is not associated with glob

Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients

✍ Richard M. Camicioli; Thomas P. Bouchard; Martin J. Somerville 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

## Abstract Levodopa (L‐dopa) treatment of Parkinson's disease (PD) is associated with elevated homocysteine (Hcy). To examine the relationship between Hcy, methylenetetrahydrofolate reductase polymorphisms (MTHFR: 677C/T; 1298A/C), and B‐vitamins in older PD patients and whether Hcy or MTHFR polym